文献速递炎症性肠病

克罗恩病排除饮食联合部分肠内营养在随机对照试验中诱导持续缓解

Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial.
PubMed 文献 · Gastroenterology · 2019-06-04

该12周前瞻性随机对照试验纳入轻中度克罗恩病患儿,比较克罗恩病排除饮食(CDED)联合部分肠内营养(PEN)与全肠内营养(EEN)的疗效。结果显示CDED+PEN耐受性优于EEN,第6周两组诱导缓解率无显著差异,第12周CDED+PEN组无激素持续缓解率显著更高,且伴随粪便微生物组与炎症指标改善。

要点

  • CDED联合PEN的耐受率97.5%,显著高于EEN的73.6%(P=0.002)。
  • 第6周CDED+PEN组缓解率75% vs EEN组59%,差异未达统计学显著(P=0.38)。
  • 第12周CDED+PEN组持续缓解率75.6% vs EEN后自由饮食+PEN组45.1%(P=0.01)。

核心结论

  • CDED联合PEN在轻中度克罗恩病患儿中耐受性优于EEN,两者第6周均可有效诱导缓解,而CDED+PEN在第12周诱导持续缓解的比例显著高于EEN。

研究设计与样本

  • 12周前瞻性随机对照试验,纳入轻中度克罗恩病患儿,随机分为CDED+50%热量配方(Modulen,雀巢)6周后CDED+25%PEN至第12周(n=40,第1组)或EEN 6周后自由饮食+25%PEN至第12周(n=38,第2组)。
  • 因不耐受48小时内退出4例,最终74例(平均年龄14.2±2.7岁)纳入缓解分析。
  • 主要终点为饮食耐受性;次要终点为第6周意向性治疗(ITT)缓解(儿童克罗恩病活动指数评分低于10)及第12周无激素ITT持续缓解。

主要发现

  • CDED联合PEN在39例儿童中耐受(97.5%),EEN在28例儿童中耐受(73.6%)(P=0.002;CDED+PEN耐受的比值比为13.92;95%CI 1.68-115.14)。
  • 第6周,CDED+PEN组40例中30例(75%)达到无激素缓解,EEN组34例中20例(59%)达到无激素缓解(P=0.38)。
  • 第12周,CDED+PEN组37例中28例(75.6%)达到无激素缓解,EEN后PEN组31例中14例(45.1%)达到无激素缓解(P=0.01;CDED+PEN组缓解的比值比为3.77;95%CI 1.34-10.59)。
  • 在CDED+PEN组中,无激素缓解与炎症持续降低(基于血清C反应蛋白和粪便钙卫蛋白水平)及粪便变形菌门减少相关。

临床怎么用

  • 作者结论认为这些数据支持使用CDED联合PEN诱导克罗恩病患儿缓解。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Exclusive enteral nutrition (EEN) is recommended for children with mild to moderate Crohn's disease (CD), but implementation is challenging. We compared EEN with the CD exclusion diet (CDED), a whole-food diet coupled with partial enteral nutrition (PEN), designed to reduce exposure to dietary components that have adverse effects on the microbiome and intestinal barrier. METHODS: We performed a 12-week prospective trial of children with mild to moderate CD. The children were randomly assigned to a group that received CDED plus 50% of calories from formula (Modulen, Nestlé) for 6 weeks (stage 1) followed by CDED with 25% PEN from weeks 7 to 12 (stage 2) (n = 40, group 1) or a group that received EEN for 6 weeks followed by a free diet with 25% PEN from weeks 7 to 12 (n = 38, group 2). Patients were evaluated at baseline and weeks 3, 6, and 12 and laboratory tests were performed; 16S ribosomal RNA gene (V4V5) sequencing was performed on stool samples. The primary endpoint was dietary tolerance. Secondary endpoints were intention to treat (ITT) remission at week 6 (pediatric CD activity index score below 10) and corticosteroid-free ITT sustained remission at week 12. RESULTS: Four patients withdrew from the study because of intolerance by 48 hours, 74 patients (mean age 14.2 ± 2.7 years) were included for remission analysis. The combination of CDED and PEN was tolerated in 39 children (97.5%), whereas EEN was tolerated by 28 children (73.6%) (P = .002; odds ratio for tolerance of CDED and PEN, 13.92; 95% confidence interval [CI] 1.68-115.14). At week 6, 30 (75%) of 40 children given CDED plus PEN were in corticosteroid-free remission vs 20 (59%) of 34 children given EEN (P = .38). At week 12, 28 (75.6%) of 37 children given CDED plus PEN were in corticosteroid-free remission compared with 14 (45.1%) of 31 children given EEN and then PEN (P = .01; odds ratio for remission in children given CDED and PEN, 3.77; CI 1.34-10.59). In children given CDED plus PEN, corticosteroid-free remission was associated with sustained reductions in inflammation (based on serum level of C-reactive protein and fecal level of calprotectin) and fecal Proteobacteria. CONCLUSION: CDED plus PEN was better tolerated than EEN in children with mild to moderate CD. Both diets were effective in inducing remission by week 6. The combination CDED plus PEN induced sustained remission in a significantly higher proportion of patients than EEN, and produced changes in the fecal microbiome associated with remission. These data support use of CDED plus PEN to induce remission in children with CD. Clinicaltrials.gov no: NCT01728870.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Levine A, Wine E, Assa A, et al. Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial. Gastroenterology. 2019. PMID: 31170412. doi:10.1053/j.gastro.2019.04.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。